foxo4 dri senolytic peptide human trial 2024 2025 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells general inflammation SS-31 Reconstitution: 5mg + Strength:2000mcg
SKU: 33863667072
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16